The Clinical Trial That Should (But Probably Won't) Close the Book on Ivermectin - American Council on Science and Health

The controversy surrounding ivermectin as a therapy for COVID has been longstanding and fierce. A recent paper in NEJM may or may not settle the ongoing debate. But the paper is full of data. Here is a condensed look at the key numbers.

About a week ago, news outlets reported that a large randomized controlled trial showed that ivermectin had no impact on COVID. At that time, only scant data on which the conclusions were based were … [+6315 chars]

full article...